plicamycin has been researched along with chromomycin a3 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banville, DL; Keniry, MA; Shafer, RH | 1 |
| Chatterjee, S; Conforto, A; Ratan, RR; Ryu, H; Zaman, K | 1 |
| Garcia-Ferrer, I; Mansilla, S; Méndez, C; Portugal, J; Salas, JA | 1 |
3 other study(ies) available for plicamycin and chromomycin a3
| Article | Year |
|---|---|
NMR investigation of mithramycin A binding to d(ATGCAT)2: a comparative study with chromomycin A3.
Topics: Base Sequence; Chromomycin A3; DNA; Hydrogen; Magnetic Resonance Spectroscopy; Plicamycin; Protein Conformation | 1990 |
Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons.
Topics: Animals; Apoptosis; Base Sequence; Brain; Cell Culture Techniques; Chromomycin A3; DNA Damage; Electrophoresis; Microscopy, Phase-Contrast; Neurodegenerative Diseases; Neurons; Oxidative Stress; Plicamycin; Rats; Rats, Sprague-Dawley | 2001 |
Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationships.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chromomycin A3; Chromomycins; Colonic Neoplasms; Deoxyribonucleases, Type II Site-Specific; DNA Restriction Enzymes; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Plicamycin; Prostatic Neoplasms; Structure-Activity Relationship | 2010 |